¥1,272.00
0.08%
Tokyo, Sep 25, 02:49 pm JST. Closed.
ISIN
JP3154390003
Symbol
3183

Win-partners Co.,ltd. Stock price

¥1,276.00
-3.00 0.23% 1M
-173.00 11.94% 6M
-66.00 4.92% YTD
-80.00 5.90% 1Y
+174.00 15.79% 3Y
+294.23 29.97% 5Y
-311.61 19.63% 10Y
+497.00 63.80% 20Y
Tokyo, Closing price Fri, Sep 25 2026
+5.00 0.39%
ISIN
JP3154390003
Symbol
3183

Is Win-partners Co.,ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
¥36.5b
Enterprise Value
¥21.5b
Net debt
positive
Cash
¥15.0b
Shares outstanding
27.5m
Valuation (TTM | estimate)
P/E
17.2
P/S
0.4 | -
EV/Sales
0.2 | -
EV/FCF
-
P/B
1.6
Dividends
DPS
¥52.00
Yield 1Y | 5Y
4.1% | 3.9%
Growth 1Y | 5Y
4.0% | 9.8%
Payout 1Y | 3Y
73.8% | 73.5%
Increased
8 Years
Financials (TTM | estimate)
Revenue
¥92.3b | -
EBITDA
-
EBIT
¥2.9b
Net Income
¥2.0b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
10.0% | -
EBITDA
-
EBIT
0.2%
Net Income
-3.0%
Free Cash Flow
-
Margin
Gross
11.6%
EBITDA
-
EBIT
3.2%
Net
2.2%
Free Cash Flow
-
Financial Health
Equity Ratio
46.0%
Return on Equity
9.1%
ROCE
12.1%
ROIC
21.4%
Debt/Equity
0.0
More
EPS
¥74.2
FCF per Share
-
Short interest
-
Employees
630
Rev per Employee
¥143.5m

Financial data from Win-partners Co.,ltd.

Jun '26
+/-
%
92,277 92,277
10% 10%
100%
- Direct Costs 81,548 81,548
11% 11%
88%
10,728 10,728
6% 6%
12%
- Selling and Administrative Expenses 7,812 7,812
9% 9%
8%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 2,929 2,929
0% 0%
3%
Net Profit 2,040 2,040
3% 3%
2%

In millions JPY.

Don't miss a Thing! We will send you all news about Win-partners Co.,ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

WIN-Partners Co., Ltd. engages in the management of its group of companies that sell medical devices. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 630 full-time employees. The company went IPO on 2013-04-01. The firm is mainly in the provision of medical device, such as catheters used in ischemic heart disease, pacemakers used in cardiac rhythm management area, artificial blood vessels used for cardiovascular surgery area, embolization coil used in peripheral vascular disease and brain surgery, as well as the provision of large -scale medical equipment, such as computed tomography equipment (CT) used in the radiology department and the operating room.

Head office Japan
CEO Mr. Akizawa
Employees 630
Website www.win-partners.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today